Abnormal CacyBP/SIP levels have been found in pancreatic cancer, gastric cancer, colorectal cancer, osteogenic sarcoma, melanoma, kidney cancer, breast cancer, brain cancer (16). This evidence concerns the gene CACYBP and melanoma.